A clinical study of MK-3214 in healthy people (MK-3214-001)
MK-3214-001
Phase 1 other active
Quick answer
A clinical study of MK-3214 in healthy people (MK-3214-001) for Hypercholesterolaemia is a Phase 1 program (other) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Hypercholesterolaemia
- Phase
- Phase 1
- Modality
- other
- Status
- active